Crestone Asset Management LLC Merck & Co., Inc. Transaction History

Crestone Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$102.95 - $114.33 $317,909 - $353,051	3,088 New	3,088 $317,000
Q2 2020 Mar 12, 2021	SELL	$70.42 - $80.13 $224,780 - $255,774	-3,192 Closed	0 $0
Q1 2020 Mar 12, 2021	BUY	$63.36 - $87.82 $202,245 - $280,321	3,192 New	3,192 $246,000
Q3 2017 Mar 12, 2021	SELL	$58.67 - $63.13 $222,828 - $239,767	-3,798 Closed	0 $0
Q2 2017 Mar 12, 2021	BUY	N/A	3,798	3,798 $243,000

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Crestone Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Crestone Asset Management LLC with notifications on news.